Supply Chain Intelligence

MAIA Biotechnology, Inc. Supply Chain

MAIA supply chain intelligence for MAIA Biotechnology, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

MAIA ·Last updated 2026-07-30 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

7Suppliers
0Customers
2Debt Items
20Related Chains

MAIA Biotechnology, Inc. Suppliers

TickerNameConfidenceEvidence
H-C-WAINWRIGHT-CO-LLC H-C-WAINWRIGHT-CO-LLC 92% the Company's sales agent thereunder
KONIK-CAPITAL-PARTNERS-LLC KONIK-CAPITAL-PARTNERS-LLC 92% the Company agreed to issue and sell in an underwritten public offering (the “Offering”) an aggregate of 20,000,000 shares (the “Shares”) of the Company’s common stock, par value $0.0001 per share (“…
REGN Regeneron Pharmaceuticals, Inc. 92% In February 2021, the Company entered into a Drug Supply Agreement (the “Drug Supply Agreement”) with Regeneron Pharmaceuticals, Inc. (“Regeneron”) to perform one clinical trial for the treatment of …
REGN Regeneron Pharmaceuticals, Inc. 92% Reciprocal relationship from REGN graph: Reciprocal relationship from MAIA graph: In February 2021, the Company entered into a Drug Supply Agreement (the “Drug Supply Agreement”) with Regeneron Pharm…
UTSW UTSW 90% Pursuant to the UTSW1 Agreement, the Company paid to UTSW a nominal one-time upfront license fee.
ORANY ORANY 72% ncy. In addition to its own review, the FDA may refer applications for novel drug or biological products or drug or biological products which present difficult questions of safety or efficacy to an a…
ORANY ORANY 72% Reciprocal relationship from ORANY graph: Reciprocal relationship from MAIA graph: Reciprocal relationship from ORANY graph: Reciprocal relationship from MAIA graph: Reciprocal relationship from ORAN…

MAIA Biotechnology, Inc. Customers

No clients on recordNo downstream customers found in our database for MAIA Biotechnology, Inc..

MAIA Biotechnology, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
MAIA-DEBT-10859 Xbrl Convertible 90% xbrl convertible detail from xbrl 2021-12-31.
MAIA-DEBT-10858 Warrants outstanding: 452731 90% xbrl warrant detail from xbrl 2025-12-31.

MAIA Biotechnology, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for MAIA Biotechnology, Inc..

MAIA Biotechnology, Inc. Ownership

HolderNameConfidenceEvidence
MAIA-OWNER-SOLAS-CAPITAL-MANAGEMENT-LLC Solas Capital Management, LLC 90% 13F overlay lists Solas Capital Management, LLC as top holder; 32 tracked holders.

MAIA Biotechnology, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
ORANY ORANGE 100.00 1 ['supplier']
REGN Regeneron Pharmaceuticals, Inc. 100.00 1 ['supplier']
AMZE Amaze Holdings, Inc. 50.00 2
CPRX Catalyst Pharmaceuticals, Inc. 50.00 2
AYTU Aytu BioPharma, Inc. 50.00 2
CTMX CytomX Therapeutics, Inc. 50.00 2
DARE Daré Bioscience, Inc. 50.00 2
CNOB ConnectOne Bancorp, Inc. 50.00 2
FATE Fate Therapeutics, Inc. 50.00 2
CANF Can-Fite BioPharma Ltd. 50.00 2
DFTX Definium Therapeutics, Inc. 50.00 2
CHUC Charlie's Holdings, Inc. 50.00 2
CLNE Clean Energy Fuels Corp. 50.00 2
FENC Fennec Pharmaceuticals Inc. 50.00 2
EQR Equity Residential 50.00 2
D Dominion Energy, Inc. 50.00 2
DWTX Dogwood Therapeutics, Inc. 50.00 2
EDSA Edesa Biotech, Inc. 50.00 2
ESS Essex Property Trust, Inc. 50.00 2
CYCN Cyclerion Therapeutics, Inc. 50.00 2
View MAIA supply chain intel →

Explore the full interactive supply chain map for MAIA Biotechnology, Inc..

Open MAIA supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map